Pasar al contenido principal

-

FJCI-2014-19673

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Juan de la Cierva Formación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario CENTRO INVESTIGACION BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation

  • Puerto, Ana del
  • Pose-Utrilla, Julia
  • Simón-García, Ana
  • López-Menéndez, Celia
  • Jiménez, Antonio J.
  • Porlan, Eva
  • Pajuelo, Luis S. M.
  • Cano-García, Guillermo
  • Martí-Prado, Beatriz
  • Sebastián-Serrano, Álvaro
  • Sánchez-Carralero, Marina P.
  • Cesca, Fabrizia
  • Schiavo, Giampietro
  • Ferrer, Isidro
  • Fariñas, Isabel
  • Campanero, Miguel R.
  • Iglesias, Teresa
Several psychiatric, neurologic and neurodegenerative disorders present increased brain ventricles volume, being hydrocephalus the disease with the major manifestation of ventriculomegaly caused by the accumulation of high amounts of cerebrospinal fluid (CSF). The molecules and pathomechanisms underlying cerebral ventricular enlargement are widely unknown. Kinase D interacting substrate of 220 kDa (KIDINS220) gene has been recently associated with schizophrenia and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity (SINO syndrome), diseases frequently occurring with ventriculomegaly. Here we show that Kidins220, a transmembrane protein effector of various key neuronal signalling pathways, is a critical regulator of CSF homeostasis. We observe that both KIDINS220 and the water channel aquaporin-4 (AQP4) are markedly downregulated at the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. We also find that Kidins220 deficient mice develop ventriculomegaly accompanied by water dyshomeostasis and loss of AQP4 in the brain ventricular ependymal layer and astrocytes. Kidins220 is a known cargo of the SNX27-retromer, a complex that redirects endocytosed plasma membrane proteins (cargos) back to the cell surface, thus avoiding their targeting to lysosomes for degradation. Mechanistically, we show that AQP4 is a novel cargo of the SNX27-retromer and that Kidins220 deficiency promotes a striking and unexpected downregulation of the SNX27-retromer that results in AQP4 lysosomal degradation. Accordingly, SNX27 silencing decreases AQP4 levels in wild-type astrocytes whereas SNX27 overexpression restores AQP4 content in Kidins220 deficient astrocytes. Together our data suggest that the KIDINS220-SNX27-retromer-AQP4 pathway is involved in human ventriculomegaly and open novel therapeutic perspectives., This work was supported by Spanish grants SAF2017-88885-R to TI and SAF2017-88881-R to MRC from the Spanish Ministerio de Economía y Competitividad/Agencia Estatal de Investigación/European Union Funds for Regional Development (MINECO/AEI/ FEDER, EU); by Comunidad de Madrid through the European Social Fund (ESF)-financed programme NEUROMETAB-CM (B2017/BMD-3700) to TI and AORTASANA-CM (B2017/BMD-3676) to MRC; by ‘La Caixa’ Banking Foundation project HR18-00068 to MRC; by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) CB06/05/1122 to TI and collaborative grant CIBERNED PI2018/06 to TI and IFa; by grant PID2019-104763RB-100 and Ramón y Cajal programme contract (RYC-2014-15991), both from MINECO/AEI/FEDER (EU) to EP; by Wellcome Trust Senior Investigator Award (107116/Z/15/Z), the European Union’s Horizon 2020 Research and Innovation programme under grant agreement 739572 and a UK Dementia Research Institute Foundation award, all to GS; by grant PI19/00778 to AJJ from the Spanish Instituto de Salud Carlos III, co-funded by FEDER (EU); by Spanish grants from FEDER/Ministerio de Ciencia e Innovación (MICI)–AEI (SAF2017-86690-R), Network of Excellence iDIFFER (RED2018-102723-T), Instituto de Salud Carlos III (CIBERNED CB06/05/0086 and RETIC Tercel RD16/0011/0017) and Generalitat Valenciana (Prometeo 2017/030) to IFa. ADP was funded by a Juan de la Cierva Formación programme contract (FJCI-2014-19673; MINECO) and CIBERNED; JP-U was contracted by SAF2017-88885-R grant; AS-S was contracted by grants CIBERNED-PI2015-2/06 and PI2018/06, and SAF2017-88885-R; AS-G was funded by a contract from B2017/BMD-3700 grant and LSMP by a PhD training contract (PRE2018-086989) associated to grant SAF2017-88885-R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kidins220 sets the threshold for survival of neural stem cells and progenitors to sustain adult neurogenesis

  • Puerto, Ana del
  • Lopez-Fonseca, Coral
  • Simón-García, Ana
  • Martí-Prado, Beatriz
  • Barrios-Muñoz, Ana L.
  • Pose-Utrilla, Julia
  • López-Menéndez, Celia
  • Alcover-Sanchez, Berta
  • Cesca, Fabrizia
  • Schiavo, Giampietro
  • Campanero, Miguel R.
  • Fariñas, Isabel
  • Iglesias, Teresa
  • Porlan, Eva
17 Pág., In the adult mammalian brain, neural stem cells (NSCs) located in highly restricted niches sustain the generation of new neurons that integrate into existing circuits. A reduction in adult neurogenesis is linked to ageing and neurodegeneration, whereas dysregulation of proliferation and survival of NSCs have been hypothesized to be at the origin of glioma. Thus, unravelling the molecular underpinnings of the regulated activation that NSCs must undergo to proliferate and generate new progeny is of considerable relevance. Current research has identified cues promoting or restraining NSCs activation. Yet, whether NSCs depend on external signals to survive or if intrinsic factors establish a threshold for sustaining their viability remains elusive, even if this knowledge could involve potential for devising novel therapeutic strategies. Kidins220 (Kinase D-interacting substrate of 220 kDa) is an essential effector of crucial pathways for neuronal survival and differentiation. It is dramatically altered in cancer and in neurological and neurodegenerative disorders, emerging as a regulatory molecule with important functions in human disease. Herein, we discover severe neurogenic deficits and hippocampal-based spatial memory defects accompanied by increased neuroblast death and high loss of newly formed neurons in Kidins220 deficient mice. Mechanistically, we demonstrate that Kidins220-dependent activation of AKT in response to EGF restraints GSK3 activity preventing NSCs apoptosis. We also show that NSCs with Kidins220 can survive with lower concentrations of EGF than the ones lacking this molecule. Hence, Kidins220 levels set a molecular threshold for survival in response to mitogens, allowing adult NSCs growth and expansion. Our study identifies Kidins220 as a key player for sensing the availability of growth factors to sustain adult neurogenesis, uncovering a molecular link that may help paving the way towards neurorepair., This work was funded by grants RYC2014-15991 (MINECO/ESF), SAF2015-67756-R (MCIN/AEI /10.13039/501100011033 and by ERDF “A way of making Europe") and PID2019-104763RB-I00 to EP, PID2020-115218RB-I00 to TI, PID2020-117937GB-I00 to IF, PID2020-115217RB-I00 to MRC, funded by MCIN/AEI/ 10.13039/501100011033; by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) and collaborative grants CIBERNED-2015-2/06 and 2018/06 to TI and IF; by PROMETEO/2021/028 of Generalitat Valenciana to IF; by Wellcome Senior Investigator Awards (107116/Z/15/Z and 223022/Z/21/Z) and a UK Dementia Research Institute Foundation award (UKDRI-1005) to GS. ADP was supported by grant FJCI-2014-19673 funded by MCIN/AEI/ 10.13039/501100011033 and by ESF “Investing in your future”; and a CIBERNED contract; AS-G was supported by a contract associated to PID2020-115218RB-I00 project; EP was supported by a Ramón y Cajal contract (RYC2014-15991, MINECO/ESF), ALB-M by grant FPI BES-2016-078481 associated to SAF2015-67756-R to EP. JP-U was supported by a CIBERNED contract. CLF is recipient of a FPI grant funded by UAM. The cost of this publication has been paid in part by “ERDF A way of making Europe” funds., Peer reviewed